Detection of mitochondrial dysfunction by EPR technique in mouse model of dilated cardiomyopathy

Free Radical Biology and Medicine

Volumn 45, Issue 3, 2008, Pages 321-328

  Elas, Martyna ^a   Bielanska, Joanna ^a   Pustelny, Katarzyna ^a   Plonka, Przemyslaw M ^a   Drelicharz, Lukasz ^b   Skorka, Tomasz ^c   Tyrankiewicz, Urszula ^c   Wozniak, Miroslaw ^b   Heinze Paluchowska, Sylwia ^c   Walski, Michal ^d   Wojnar, Leszek ^e   Fortin, Dominique ^f   Ventura Clapier, Renee ^f   Chlopicki, Stefan ^b  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c INSTITUTE OF NUCLEAR PHYSICS   (Poland)

^d MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^e CRACOW UNIVERSITY OF TECHNOLOGY   (Poland)

^f Universite Paris Sud   (France)

Author keywords

EPR; Heart failure; Iron; Mitochondria; Semiquinones

Indexed keywords

CITRATE SYNTHASE; CYTOCHROME C OXIDASE; FERROUS SULFIDE; IRON; SEMIQUINONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON SPIN RESONANCE; ELECTRON TRANSPORT; ENZYME ACTIVITY; HEART FAILURE; HEART FUNCTION; HEART MITOCHONDRION; LUNG CONGESTION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ULTRASTRUCTURE; WILD TYPE;

ANIMALS; CARDIOMYOPATHY, DILATED; DISEASE MODELS, ANIMAL; ELECTRON SPIN RESONANCE SPECTROSCOPY; IRON; MAGNETIC RESONANCE IMAGING; MICE; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA, HEART; QUINONES;

MUS;

EID: 46749083764     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.04.016     Document Type: Article

References (49)

1. Huss J.M., and Kelly D.P. Mitochondrial energy metabolism in heart failure: a question of balance. J. Clin. Invest. 115 (2005) 547-555
2. Hirano M., Marti R., Ferreiro-Barros C., Vila M.R., Tadesse S., Nishigaki Y., Nishino I., and Vu T.H. Defects of intergenomic communication: autosomal disorders that cause multiple deletions and depletion of mitochondrial DNA. Semin. Cell Dev. Biol. 12 (2001) 417-427
3. Ide T., Tsutsui H., Kinugawa S., Utsumi H., Kang D., Hattori N., Uchida K., Arimura K., Egashira K., and Takeshita A. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ. Res. 85 (1999) 357-363
4. Garnier A., Fortin D., Delomenie C., Momken I., Veksler V., and Ventura-Clapier R. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J. Physiol. 551 (2003) 491-501
5. Maurer I., and Zierz S. Myocardial respiratory chain enzyme activities in idiopathic dilated cardiomyopathy, and comparison with those in atherosclerotic coronary artery disease and valvular aortic stenosis. Am. J. Cardiol. 72 (1993) 428-433
6. Vogt A.M., and Kubler W. Heart failure: is there an energy deficit contributing to contractile dysfunction?. Basic Res. Cardiol. 93 (1998) 1-10
7. Casademont J., and Miro O. Electron transport chain defects in heart failure. Heart Fail. Rev. 7 (2002) 131-139
8. Nohl H., Gille L., and Staniek K. Intracellular generation of reactive oxygen species by mitochondria. Biochem. Pharmacol. 69 (2005) 719-723
9. Baker J.E., Felix C.C., Olinger G.N., and Kalyanaraman B. Myocardial ischemia and reperfusion: Direct evidence for free radical generation by electron spin resonance spectroscopy. Proc. Nat. Acad. Sci. U. S. A. 85 (1988) 2786-2789
10. Ruuge E. Oxidative stress and myocardial injury: spin-trapping and low-temperature EPR study. Curr. Top. Biophys. 26 (2001) 145-155
11. Ruuge E.K., Ledenev A.N., Lakomkin V.L., Konstantinov A.A., and Ksenzenko M. Free radical metabolites in myocardium during ischemia and reperfusion. Am. J. Physiol. 261 (1991) 81-86
12. Zweier J.L., Flaherty J.T., and Weisfeldt M.L. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 1404-1407
13. Baker J.E., and Kalyanaraman B. Ischemia-induced changes in myocardial paramagnetic metabolites: implications for intracellular oxy-radical generation. FEBS Lett. 244 (1989) 311-314
14. Svistunenko D.A., Davies N., Brealey D., Singer M., and Cooper C.E. Mitochondrial dysfunction in patients with severe sepsis: an EPR interrogation of individual respiratory chain components. Biochim. Biophys. Acta 1757 (2006) 262-272
15. Ledenev A.N., Lakomkin V.L., and Ruuge E.K. [Redox reactions of flavins and coenzyme Q-10 in the heart during experimental ischemia and reperfusion]. Biofizika 31 (1986) 687-690
16. Keyer K., and Imlay J.A. Superoxide accelerates DNA damage by elevating free-iron levels. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 13635-13640
17. Srinivasan C., Liba A., Imlay J.A., Valentine J.S., and Gralla E.B. Yeast lacking superoxide dismutase(s) show elevated levels of "free iron" as measured by whole cell electron paramagnetic resonance. J. Biol. Chem. 275 (2000) 29187-29192
18. Musci G., Persichini T., Casadei M., Mazzone V., Venturini G., Polticelli F., and Colasanti M. Nitrosative/oxidative modifications and ageing. Mech. Ageing Dev. 127 (2006) 544-551
19. Ruuge E.K., Zabbarova I.V., Sviryaeva I.V., and Shumaev K.B. Redox status of cardiac cells. Ferritin, reactive oxygen and nitrogen species. Curr. Top. Biophys. 29 (2005) 37-45
20. Symons M.C.R. Chemical and Biochemical Aspects of Electron Spin Resonance (1978), Wiley, London 1-190
21. Aisen P., Leibman A., and Zweier J. Stoichiometric and site characteristics of the binding of iron to human transferrin. J. Biol. Chem. 253 (1978) 1930-1937
22. Foster M.A. Paramagnetic Metal Ions. In: Foster M.A. (Ed). Magnetic Resonance in Medicine and Biology (1984), Pergamon Press, Oxford 48-65
23. Chasteen N.D., Antanaitis B.C., and Aisen P. Iron deposition in apoferritin. Evidence for the formation of a mixed valence binuclear iron complex. J. Biol. Chem. 260 (1985) 2926-2929
24. Hanna P.M., Chen Y., and Chasteen N.D. Initial iron oxidation in horse spleen apoferritin. Characterization of a mixed-valence iron(II)-iron(III) complex. J. Biol. Chem. 266 (1991) 886-893
25. Stadler N., Lindner R.A., and Davies M.J. Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 949-954
26. Mende U., Semsarian C., Martins D.C., Kagen A., Duffy C., Schoen F.J., and Neer E.J. Dilated cardiomyopathy in two transgenic mouse lines expressing activated G protein alpha(q): lack of correlation between phospholipase C activation and the phenotype. J. Mol. Cell. Cardiol. 33 (2001) 1477-1491
27. Mende U., Kagen A., Cohen A., Aramburu J., Schoen F.J., and Neer E.J. Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 13893-13898
28. Heinze-Paluchowska S., Skórka T., Drelicharz L., Chlopicki S., and Jasinski A. MR imaging of mouse heart in vivo using a specialized probehead and gradient system. Pol. J. Chem. 80 (2006) 1133-1139
29. Wiesmann F., Ruff J., Engelhardt S., Hein L., Dienesch C., Leupold A., Illinger R., Frydrychowicz A., Hiller K.H., Rommel E., Haase A., Lohse M.J., and Naa S. Dobutamine-stress magnetic resonance microimaging in mice: acute changes of cardiac geometry and function in normal and failing murine hearts. Circ. Res. 88 (2001) 563-569
30. Takuma S., Suehiro K., Cardinale C., Hozumi T., Yano H., Shimizu J., Mullis-Jansson S., Sciacca R., Wang J., Burkhoff D., Di Tullio M.R., and Homma S. Anesthetic inhibition in ischemic and nonischemic murine heart: comparison with conscious echocardiographic approach. Am. J. Physiol. Heart Circ. Physiol. 280 (2001) H2364-H23670
31. Walski M., Chlopicki S., Celary-Walska R., and Frontczak-Baniewicz M. Ultrastructural alterations of endothelium covering advanced atherosclerotic plaque in human carotid artery visualised by scanning electron microscope. J. Physiol. Pharmacol. 53 (2002) 713-723
32. Beinert H. EPR spectroscopy of components of the mitochondrial electron-transfer system. Methods Enzymol. 54 (1978) 133-150
33. Srere P. Citrate synthase. Methods in Enzymol. 13 (1969) 3-11
34. Ruzicka F.J., Beinert H., Schepler K.L., Dunham W.R., and Sands R.H. Interaction of ubisemiquinone with a paramagnetic component in heart tissue. Proc. Natl. Acad. Sci. U. S. A. 72 (1975) 2886-2890
35. Davies K.J.A., and Hochstein P. Ubisemiquinone radicals in liver: implications from a mitochondrial Q cycle in vivo. Biochem. Biophys. Res. Commun. 107 (1982) 1292-1299
36. Salerno J.C., and Ohnishi T. Studies on the stabilized ubisemiquinone species in the succinate-cytochrome c reductase segment of the intact mitochondrial membrane system. Biochem. J. 192 (1980) 769-781
37. Nohl H., Gille L., Kozlov A., and Staniek K. Are mitochondria a spontaneous and permanent source of reactive oxygen species?. Redox Rep. 8 (2003) 135-141
38. Drelicharz, L.; Kozlowski, V.; Skorka, T.; Heinze-Paluchowska, S.; Jasinski, A.; Gebska, A.; Guzik, T.; Olszanecki, R.; Wojnar, L.; Mende, U.; Chlopicki, S. NO and PGI2 in coronary endothelial dysfunction in transgenic mice with dilated cardiomyopathy. Basic Res. Cardiol.2008 [Apr 22, Electronic publication ahead of print].
39. Abe H., Yamada T., Miyata K., Yoshida A., and Yabe Y. Myocardial energy metabolism of congestive and hypertrophic cardiomyopathy in man. Adv. Myocardiol. 4 (1983) 107-113
40. Heinke M.Y., Wheeler C.H., Yan J.X., Amin V., Chang D., Einstein R., Dunn M.J., and dos Remedios C.G. Changes in myocardial protein expression in pacing-induced canine heart failure. Electrophoresis 20 (1999) 2086-2093
41. Jarreta D., Orus J., Barrientos A., Miro O., Roig E., Heras M., Moraes C.T., Cardellach F., and Casademont J. Mitochondrial function in heart muscle from patients with idiopathic dilated cardiomyopathy. Cardiovasc. Res. 45 (2000) 860-865
42. Quigley A.F., Kapsa R.M., Esmore D., Hale G., and Byrne E. Mitochondrial respiratory chain activity in idiopathic dilated cardiomyopathy. J. Card. Fail. 6 (2000) 47-55
43. Lesnefsky E.J., Gudz T.I., Migita C.T., Ikeda-Saito M., Hassan M.O., Turkaly P.J., and Hoppel C.L. Ischemic injury to mitochondrial electron transport in the aging heart: damage to the iron-sulfur protein subunit of electron transport complex III. Arch. Biochem. Biophys. 385 (2001) 117-128
44. Lesnefsky E.J., Chen Q., Slabe T.J., Stoll M.S., Minkler P.E., Hassan M.O., Tandler B., and Hoppel C.L. Ischemia, rather than reperfusion, inhibits respiration through cytochrome oxidase in the isolated, perfused rabbit heart: role of cardiolipin. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H258-H267
45. Pouleur H. Diastolic dysfunction and myocardial energetics. Eur. Heart J. 11 (1990) 30-34 Suppl C
46. Bressler R., Gay R., Copeland J.G., Bahl J.J., Bedotto J., and Goldman S. Chronic inhibition of fatty acid oxidation: new model of diastolic dysfunction. Life Sci. 44 (1989) 1897-1906
47. Minotti G., Ronchi R., Salvatorelli E., Menna P., and Cairo G. Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy. Cancer Res. 61 (2001) 8422-8428
48. Myers C. The role of iron in doxorubicin-induced cardiomyopathy. Semin. Oncol. 25 (1998) 10-14
49. Oliveira P.J., and Wallace K.B. Depletion of adenine nucleotide translocator protein in heart mitochondria from doxorubicin-treated rats-relevance for mitochondrial dysfunction. Toxicology 220 (2006) 160-168